BIT's 1st International Biotechnology Congress (IBC-2017)
Highlights of the Conference

● A Plenary Forum from a Panel of Leading Experts in Biotechnology Field
● Hear and Discuss the Most Exciting Research Discoveries in Biotechnology Field with 100+ Oral Presentations
● Network with Senior Scientists, Executives and Others during Scientific and Business Sessions
● Look for a Job, Fellowship, Postdoctoral Position, or New Collaborator
● Visit over 40 Commercial and Nonprofit Exhibits Offering New Products and Services
● Kinds of Tech Tours to Famous Science Spots & Historical Sites in China

Welcome to IBC-2017

On behalf of the organizing commission, we welcome you to attend BIT's 1st International Biotechnology Congress (IBC-2017), which will be held in Xi'an, China during April 25-27, 2017. IBC-2017 aims to provide a platform for researchers and decision makers in biotechnology to present their latest findings and learn about all the important developments in biotechnology. During the congress, we will set up a series of activities such as Scientific Program, Thematic Bio-economic Forums, Exhibitions, Posters and so on. There also will be other meetings holding with IBC-2017.

Keynote Speakers

Dr. Christian Patermann
Former Director
European Commission
Germany

Dr. Robert S. Plumb
Professor
Imperial College London
UK

Dr. Martin Banwell
Professor
Australian National University
Australia

Dr. Dongping Zhong
Professor
Ohio State University
USA


Christian Paterman
Dr. Christian Paterman is Former Director European Commission, “Father” of the European Bioeconomy. He completed his Doctoral Thesis in Law at the University of Bonn in 1969. He entered the German public service in 1971 by joining the Federal Ministry of Science and Education, Bonn. From 1974-1978 he became Science Counsellor at the German Embassy in Washington D.C., USA. He then returned to the Ministry of Research and Technology where he held many positions in Germany and International Organisations, like ESA, ESO, EMBL. In 1988 he became Director of Cabinet of the German Federal Minister of Research and Technology, Dr. H. Riesenhuber. This comprised also the position of the spokesperson of the Ministry. In 1993 he was appointed Deputy Director General of the Ministry.
In 1996 he went to Brussels to become the Programme Director for “Environment” Research at the Research Directorate-General of the European Commission at Brussels where he conceived and implemented the 4th, 5th and 6th RTD Framework Programmes of the EU in this field. He was also Vice-President of the Steering Committee of IGFA (International Group of Funding Agencies in Global Environmental Changes) and elected Member of the START Scientific Committee.
Since January 2004 he was Programme Director for “Biotechnology, Agriculture & Food” Research at the Research Directorate-General of the European Commission, which from 2007 also comprised Aquaculture and Fisheries as well as Forestry. During these years he was responsible for the elaboration of the new concept of the Knowledge Based Bioeconomy (KBBE), which today is known as biobased Economy or more simply Bioeconomy in Europe. He was also appointed Chairman of the oldest Committee between EU Member States and the European Commission, the Standing Committee on Agricultural Research, SCAR. He also served for 4 years as co-chair in the important EC-US Task Force Life Sciences and Biotechnology Research. In April 2012 Dr. Christian Patermann was appointed Member in the Georgofili Academy in Florence, the oldest Science Academy in the area of agrosciences in the world.
Dr. Patermann is author of more than 100 articles, books and other contributions to Science, Research and Technology in particular in Space, Nuclear and non-Nuclear Energy, Nuclear Proliferation, Environment and Global Changes, Marine Research, Biotechnology, Aquaculture, Food, Forestry and Fisheries.


Robert Plumb
Dr. Robert Plumb is Professor at Imperial College in the Department Surgery and Cancer, Professor in Analytical Chemistry at Kings College London, Director of Metabolic Phenotyping and Stratified Medicine in the Waters Health Sciences Business Operations Division, based in Milford, Massachusetts.
Professor Plumb has published over 100 papers on the subject of HPLC/MS and NMR for bioanalysis, metabolomics and metabolite identification. He is a recognized expert in the use of liquid chromatography with mass spectrometry, capillary scale LC, purifications scale LC and metabonomics, giving many invited papers at international meetings around the world. After obtaining an Honors Degree in Chemistry from the University of Hertfordshire in 1992, he started work at Glaxo Research and Development Drug Metabolism Department. During his time at Glaxo and later GlaxoWellcome he continued his research in liquid chromatography combined with NMR and mass spectrometry for metabolite identification and bioanalysis obtaining his Ph.D. in 1999. Dr. Plumb continued his work for GlaxoWellcome with the responsibility of metabolite identification using HPLC/MS/NMR and new analytical technology development. In 2001 he moved to Waters Corporation in Milford, MA, USA where he was responsible for the Life Science Chromatography Group and latterly LC/MS applications in the Pharmaceutical Market Development Group before becoming the Director of Metabolic Phenotyping. He is a Fellow of the Royal Society of Chemistry. In 2014 he was awarded Highly Cited Researcher by Thompson Reuters.


Martin Banwell
Dr. Martin Banwell is Professor in the College of Physical & Mathematical Sciences, Australian National University. He graduated from Victoria University of Wellington with a B.Sc. (Hons) and Ph.D. and has since held positions at Ohio State University (1979-1980), University of Adelaide (1980-1981), University of Auckland (1982-1986), University of Melbourne (1986-1992), ETH Zurich (1991-1992), University of Melbourne (1993-1994) before his appointment as Senior Fellow at The Research School of Chemistry in 1995. Currently Dr. Banwell is Foreign Visiting Researcher at Hiroshima University, Asia-Pacific Representative, Advisory Board to the International Society for Heterocyclic Chemistry, Chemistry Consultant for CSIRO Molecular Science and Member, Australian Research Council College of Experts.
He was awarded Fellowships of the Royal Australian Institute of Chemistry (1992), the Japan Society for the Promotion of Science (1999), the Australian Academy of Science (2004) and The Royal Society of Chemistry (2009). He was also made an Honorary Fellow of the Royal Society of New Zealand (2000), Erskine Fellow of the University of Canterbury (2005) and elected Fellow of the World Innovation Foundation (2005).
His group’s activities continue to be focused on the development of new synthetic strategies and methodologies as well as the application of these in the total synthesis of biologically active natural products and certain analogues.


Dongping Zhong
Dr. Dongping Zhong is Robert Smith Professor of Physics and Professor of Chemistry and Biochemistry at The Ohio State University. He received his B.S. in laser physics from Huazhong University of Science and Technology (China) and his Ph.D. in Chemistry from California Institute of Technology in 1999 under Prof. Ahmed H. Zewail. For his Ph.D. work, Dr. Zhong received The Herbert Newby McCoy Award and the Milton and Francis Clauser Doctoral Prize from Caltech. He continued his postdoctoral research in the same group with focus on protein dynamics. In 2002, he joined The Ohio State University as an Assistant Professor and currently he is Robert Smith Professor of Physics and Professor of Chemistry and Biochemistry.
Dr. Zhong is the Packard Fellow, Sloan Fellow, Camille Dreyfus Teacher-Scholar, Fellow of American Physical Society and The American Association for the Advancement of Science (AAAS), as well as the Recipient of the NSF CAREER Award and the Outstanding Young Researcher Award.
Research in the Dr. Zhong’s group is directed towards understanding the nature of elementary processes in biological systems. They relate dynamics and structures to functions at the most fundamental level with state-of-the-art femtosecond lasers and molecular biology techniques. The laboratory ultimately will have the capability of time resolution from femtosecond to millisecond (second); biological systems can be prepared and studied at the single molecule level. They are currently focusing on studies of molecular recognition and ultrafast protein/enzyme dynamics of several important biological systems.

Renowned Speakers More

 

Dr. Charlie Zhang,
Sinopec (China Petroleum & Chemical Corporation), China
Dr. Takao Ito, Manufacturing Sciences and Technology Japan and Korea, Merck Life Sciences, Japan

Dr. Zhijian Liu,

Process R&D Department, MRL, Merck & Co., Inc., Rahway, New Jersey, USA
Dr. Koon-Yang Lee,
Imperial College London, UK

Dr. Diannan Lu,

Tsinghua University, China

Dr. Hari Sunkara,
DuPont, USA

Dr. Jim Jem,

Corbion nv, Netherlands

Dr. Yucheng Zhou,

Novozymes Household Care R&D, China

Dr. Peng-Sheng Wei,

National Sun Yat-Sen University, Taiwan

Dr. Jitka Eryilmaz,

SANKO textile/İSKO, Turkey
Dr. Hajime Hirao, Nanyang Technological University, Singapore Dr. Zhonghua Sun, Curtin University, Australia

Dr. Pao Chi Chen,

Lunghwa University of Science and Technology, Taiwan

Dr. Hong Liang,

Zhongkai University of Agriculture and Engineering, China

Dr. Giulio Filippo Tarro,

Foundation T. & L. de Beaumont Bonelli for cancer research, Italy

Dr. Sae-Eun Oh,

Hanbat National University, South Korea

Dr. Yuanda Song,

Shandong University of Technology, China

Dr. Yongmei Zheng,

Beihang University, China

Dr. Weimin Huang,

Nanyang Technological University, Singapore

Dr. Shaobin Zhu,

Finnegan, USA

Dr. Franz E. Weber,

University of Zurich, Switzerland

Dr. Lee D. Wilson,

University of Saskatchewan, Canada

Dr. Kang Taek Lee,

Gwangju Institute of Science and Technology (GIST), South Korea

Dr. Patrick van Rijn,

University Medical Center Groningen, The Netherlands
Dr. Jinpeng Wang, Jiangnan University, China

Dr. Lei Chen,

Tianjin University, China

Dr. Shu-Ru Chung,

National Formosa University, Taiwan

Dr. Junling Shi,

Northwestern Polytechnical University, China

Dr. Natalia Rudenko,

Institute of Basic Biological Problems, Russian Academy of Sciences, Russia

Dr. Mel Luetkens,

Elevance Renewable Sciences, USA

 

Scenery of Xi’anMore

 

Xi'an is the capital of Shaanxi province, and a sub-provincial city in the People's Republic of China. One of the oldest cities in China, with more than 3,100 years of history, the city was known as Chang'an before the Ming Dynasty. Xi'an is one of the Four Great Ancient Capitals of China, having held the position under several of the most important dynasties in Chinese history, including Zhou, Qin, Han, Sui, and Tang. Xi'an is the eastern terminus of the Silk Road and home to the Terracotta Army of Emperor Qin Shi Huang.
Since the 1990s, as part of the economic revival of interior China especially for the central and northwest regions, the city of Xi'an has re-emerged as an important cultural, industrial and educational centre of the central-northwest region, with facilities for research and development, national security and China's space exploration program. It is now one of the most populous built-up areas in inland China with 7,168,005 inhabitants, including urban parts of Xianyang (Weicheng and Qindu districts

China Local Time
Days to Go!


News Released

● Speaking Proposals are Now being Accepted, Submit the Abstract Right Now
REGISTER NOW to secure your attendance
●  Scientific Program has been released 
● Call for collaborative partners, media and journal

Honorary Chair

Dr. Yuxin Yin,
Dean & Director, Peking University, China


Yuxin Yin
Dr. Yuxin Yin is Dean in School of Basic Medical Sciences, Director in Institute of Systems Biomedicine, Peking University Health Science Center, Peking University, China
Dr. Yin received his Ph.D. in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill in 1997 and got postdoctoral training in Princeton University. In 1999, he was appointed as a tenure-track Assistant Professor in Columbia University and was promoted to the Associate Professor in 2007. He was recruited as a National One-thousand Talent Plan to the Peking University Health Science Center in 2010. His research field is cancer research with focus on the roles of tumor suppressors p53 and PTEN in cell cycle regulation, apoptosis and genomic stability. He was the first one to find a fundamental role for p53 in maintaining genomic stability (Cell). Also, it is first reported that PTEN plays a fundamental role in the maintenance of chromosome stability (Cell). In Peking University, Dr. Yin has made great progress in studying the PTEN pathway in genome stability and tumor suppression. Recently, his group revealed a novel mechanism of alternative translation of protein and discovered a new member of the PTEN protein family named PTENα (Cell Metabolism). These studies may provide new insights into the mechanism by which PTEN maintains genomic stability and suppresses tumorigenesis.

Hosting Organization
whtslogo.JPG

World High-Tech Society

Operating Organizations


Zhen-Ao Group


SHUANGDI, INC.

BIT Group Global Ltd.

Supporting Organizations




The Argentine Genetics Society (SAG) 

Official Travel Agency

BIT World Travel Service, Inc.

Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411- 84799609-839, Fax: 0086-411-84799629
Copyright © 2014-2015 BIT Congress Inc.